Market Cap

Organon & Co. Market Capitalization:

$5.17 Billion

USD as of July 1, 2024

business Organon & Co. Company Profile

Organon & Co. Main Stock Listing

NYSE: OGN

Market Capitalization History of Organon & Co.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Organon & Co. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $3.74 B -48.92%
Jan. 1, 2023 $7.32 B -8.48%
Jan. 1, 2022 $8.00 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Organon & Co. Categories

United States languages Healthcare languages Drug Manufacturers—General
United States Healthcare United States Drug Manufacturers—General

Stocks & Indices

Organon & Co. has the following listings and related stock indices.


Stock: NYSE: OGN

Stock: FSX: 7XP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.